Prossnitz; Eric R.

Patent Applications and Registrations

Patent applications and USPTO patent grants for Prossnitz; Eric R..The latest application filed is for "method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating gpr30/gper activity".

Company Profile

8.11.9

Prossnitz; Eric R. - Albuquerque NM
Prossnitz; Eric R - Albuquerque NM US

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Method For Treating Obesity, Diabetes, Cardiovascular And Kidney Diseases By Regulating Gpr30/gper Activity App 20210186936 - Prossnitz; Eric R. ; et al.	2021-06-24
Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity Grant 10,980,785 - Prossnitz , et al. April 20, 2	2021-04-20
Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity Grant 10,682,341 - Prossnitz , et al.	2020-06-16
Method For Treating Obesity, Diabetes, Cardiovascular And Kidney Diseases By Regulating Gpr30/gper Activity App 20200113875 - Prossnitz; Eric R. ; et al.	2020-04-16
Inhibition and treatment of bacterial infections by sex-specific GPER targeting Grant 10,561,648 - Hall , et al. Feb	2020-02-18
Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity Grant 10,471,047 - Prossnitz , et al. Nov	2019-11-12
Method For Treating Obesity, Diabetes, Cardiovascular And Kidney Diseases By Regulating Gpr30/gper Activity App 20190160047 - Prossnitz; Eric R. ; et al.	2019-05-30
Method for treating obesity, diabetes, cardiovascular and kidney diseases by regulating GPR30/GPER activity Grant 10,251,870 - Prossnitz , et al.	2019-04-09
Inhibition And Treatment Of Bacterial Infections By Sex-specific Gper Targeting App 20190000830 - Hall; Pamela ; et al.	2019-01-03
Method For Treating Obesity, Diabetes, Cardiovascular And Kidney Diseases By Regulating Gpr30/gper Activity App 20180318269 - Prossnitz; Eric R. ; et al.	2018-11-08
Method For Treating Obesity, Diabetes, Cardiovascular And Kidney Diseases By Regulating Gpr30/gper Activity App 20180055826 - Prossnitz; Eric R. ; et al.	2018-03-01
Compounds for binding to ER alpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof Grant 8,487,100 - Prossnitz , et al. July 16, 2	2013-07-16
Compounds For Binding To Er Alpha/beta And Gpr30, Methods Of Treating Disease States And Conditions Mediated Through These Receptors And Identification Thereof App 20110092533 - PROSSNITZ; Eric R. ; et al.	2011-04-21
Compounds for binding to ER.alpha./.beta. and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof Grant 7,875,721 - Prossnitz , et al. January 25, 2	2011-01-25
Glutathione beads and GST fusion proteins Grant 7,785,900 - Simons , et al. August 31, 2	2010-08-31
Compounds for binding to ERalpha/beta and GPR30, methods of treating disease states and conditions mediated through these receptors and identification thereof App 20080167334 - Prossnitz; Eric R. ; et al.	2008-07-10
Multiplex analysis for high throughput discrimination of GPCR agonists and antagonists Grant 7,232,659 - Sklar , et al. June 19, 2	2007-06-19
Bead-based detection of ligand-GPCR-G protein complexes Grant 7,189,519 - Sklar , et al. March 13, 2	2007-03-13
Bead-based detection of ligand-GPCR-G protein complexes App 20030235863 - Sklar, Larry A. ; et al.	2003-12-25

Company Registrations

NCAGE Code	479E1	PROSSNITZ ERIC R
CAGE Code	479E1	PROSSNITZ, ERIC R

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.